Loading clinical trials...

Back to clinical trial search

COMPLETEDNCT03755544

Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPD

A non-interventional study to assess the clinical effectiveness of Salmeterol/fluticasone Easyhaler to achieve and maintain asthma or COPD control.

Lead sponsor: Orion Corporation, Orion Pharma•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Orion Corporation, Orion Pharma

Related studies

RECRUITINGPhase 2

Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma

NCT07301736 · Asthma

Effect of Simeox® on Residual Volume in COPD Patients With Pulmonary Hyperinflation

NCT07665931 · Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Hyperinflation

RECRUITINGPhase 2

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

NCT07646587 · COPD (Chronic Obstructive Pulmonary Disease)

Remote Anxiety Management for ICS-resistant Asthma Study

NCT06732141 · Asthma

Innate Immunity in COPD

NCT05743582 · Chronic Obstructive Pulmonary Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 28, 2020Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment231

Start dateJan 2019

Last updatedFeb 28, 2020

Condition

Asthma Chronic Obstructive Pulmonary Disease

Locations shown

Lungenpraxis

Hamburg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 28, 2020Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions